PSMD10 and dedifferentiated liposarcoma: Although further studies are needed to elucidate the mechanism(s) of gankyrin in LPS regulatory processes, these investigations suggest that gankyrin might also serve as a novel therapeutic target for WDLPS and DDLPS treatment.